|
1
|
|
879
|
+3
|
+0.3%
|
US$194억
|
|
|
2
|
Charles River Laboratories
|
286
|
+22
|
+8%
|
US$38억
|
|
|
3
|
|
186
|
+12
|
+7%
|
US$29.3억
|
|
|
4
|
|
182
|
+20
|
+12%
|
US$17.1억
|
|
|
5
|
|
177
|
-10
|
-5%
|
US$19억
|
|
|
6
|
|
169
|
-22
|
-12%
|
US$24.5억
|
|
|
7
|
Ultragenyx Pharmaceutical
|
162
|
0
|
0%
|
US$18.1억
|
|
|
8
|
|
148
|
+16
|
+12%
|
US$6.61억
|
|
|
9
|
상장폐지됨
Sangamo Therapeutics
|
136
|
-7
|
-5%
|
US$2.68억
|
|
|
10
|
|
118
|
-1
|
-0.8%
|
US$2.02억
|
|
|
11
|
상장폐지됨
Applied Genetic Technologies
|
94
|
+4
|
+4%
|
US$1.53억
|
|
|
12
|
|
81
|
+11
|
+16%
|
US$3.23억
|
|
|
13
|
|
78
|
+14
|
+22%
|
US$3276만
|
|
|
14
|
상장폐지됨
Adverum Biotechnologies
|
77
|
-5
|
-6%
|
US$4984만
|
|
|
15
|
|
74
|
+3
|
+4%
|
US$4.93억
|
|
|
16
|
Lineage Cell Therapeutics
|
74
|
+8
|
+12%
|
US$9986만
|
|
|
17
|
|
69
|
+5
|
+8%
|
US$1.47억
|
|
|
18
|
상장폐지됨
Bellicum Pharmaceuticals
|
67
|
-11
|
-14%
|
US$2.29억
|
|
|
19
|
|
66
|
+8
|
+14%
|
US$1.47억
|
|
|
20
|
|
62
|
+62
|
–
|
US$3.02억
|
|
|
21
|
|
59
|
+2
|
+4%
|
US$5996만
|
|
|
22
|
|
52
|
+8
|
+18%
|
US$2183만
|
|
|
23
|
|
52
|
+3
|
+6%
|
US$2452만
|
|
|
24
|
|
48
|
+5
|
+12%
|
US$1.16억
|
|
|
25
|
상장폐지됨
Adaptimmune Therapeutics
|
47
|
-2
|
-4%
|
US$2.6억
|
|